Literature DB >> 8699141

Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid.

P G Knight1, S Muttukrishna, N P Groome.   

Abstract

The performance of existing immunoassays and bioassays for activins is compromised by the presence of activin-binding proteins such as follistatin and alpha 2 macroglobulin (alpha 2M) in biological fluids. To overcome this problem we have developed a novel two-site enzyme immunoassay procedure for activin-A which incorporates an analyte denaturation and oxidation step. The optimized assay is sensitive (detection limit approximately 10 pg/well), precise (mean within- and between-plate coefficients of variation 4.9 and 9.1% respectively) and accurate (activin-A recovery values of 102 +/- 3 and 96 +/- 5% for bovine follicular fluid (FF) and human serum respectively). In specificity tests, high concentrations of follistatin (500 ng/ml) and alpha 2M (100 microgram/ml) did not interfere with the response signal to activin-A. In addition, no significant cross-reactivity was observed with a range of related molecules including inhibin-A, inhibin-B, activin-B (all < 0.5%), bovine pro-alpha C and follistatin (both < 0.1%). Response curves parallel to the activin-A standard curve were obtained for a variety of test samples including bovine, human, ovine and porcine FF, human sera and conditioned medium from cultured bovine and human granulosa cells. Fractionation of bovine FF by SDS-PAGE confirmed assay specificity since only one peak of activin-A immunoreactivity was detected (M(r) approximately 25 k) in eluted gel slices. However, gel-permeation chromatography showed that under physiological conditions all of the detectable activin-A in bovine FF eluted with apparent M(r) values of > 700 and 60-200 k reflecting its association with binding protein(s). Analysis of bovine FF samples (n = 76) from morphologically dominant follicles during the luteal phase showed that activin-A levels were positively correlated with inhibin-A (r = +0.54; P < 0.001) and total beta subunit immunoreactivity (r = +0.32; P < 0.005) but not with total alpha subunit immunoreactivity (r = -0.09). Classification of these follicles according to oestrogenic status showed that activin-A, inhibin-A and total beta subunit levels were highest in oestrogen-inactive follicles (P < 0.01) whereas total alpha subunit levels were lowest in these follicles (P < 0.001). Activin-A levels were measurable in all human serum samples analysed, ranging from 128 pg/ml during the normal menstrual cycle, 210 pg/ml in women undergoing ovarian hyperstimulation and approximately 500 pg/ml in postmenopausal women to over 4000 pg/ml during pregnancy. In conclusion, the present assay provides a reliable method for quantitating total (i.e. bound+free) activin-A concentrations in a variety of biological samples and should prove useful for further in vivo and in vitro studies in a range of species including man.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699141     DOI: 10.1677/joe.0.1480267

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  22 in total

1.  Reversible increase of serum activin A levels in women with Graves' disease.

Authors:  M Centanni; N Viceconti; S Luisi; F M Reis; L Gargano; F Maiani; A Franchi; G Canettieri; F Petraglia
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

2.  Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition.

Authors:  Nancy E Reame; Jane L Lukacs; Pamela Olton; Rudi Ansbacher; Vasantha Padmanabhan
Journal:  Fertil Steril       Date:  2007-04-16       Impact factor: 7.329

3.  Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia.

Authors:  Kristian L Jones; Ashley Mansell; Shane Patella; Bernadette J Scott; Mark P Hedger; David M de Kretser; David J Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

Review 4.  Plasticity of granulosa cells: on the crossroad of stemness and transdifferentiation potential.

Authors:  Edo Dzafic; Martin Stimpfel; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2013-07-28       Impact factor: 3.412

5.  Neuroendocrine control of FSH secretion: IV. Hypothalamic control of pituitary FSH-regulatory proteins and their relationship to changes in FSH synthesis and secretion.

Authors:  Tejinder P Sharma; Terry M Nett; Fred J Karsch; David J Phillips; James S Lee; Carol Herkimer; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2012-06-07       Impact factor: 4.285

Review 6.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

7.  Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep.

Authors:  Almudena Veiga-Lopez; Teresa L Steckler; David H Abbott; Kathleen B Welch; Puliyur S MohanKumar; David J Phillips; Kent Refsal; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

8.  Gonadotropic control of secretion of dimeric inhibins and activin A by human granulosa-luteal cells in vitro.

Authors:  S Muttukrishna; N Groome; W Ledger
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

9.  Mechanism of action of l-CDB-4022, a potential nonhormonal male contraceptive, in the seminiferous epithelium of the rat testis.

Authors:  Sailaja Koduri; Sheri Ann Hild; Laurent Pessaint; Jerry R Reel; Barbara J Attardi
Journal:  Endocrinology       Date:  2008-01-03       Impact factor: 4.736

10.  Placental activin A is required for follicular development during the second half of pregnancy in the golden hamster (Mesocricetus auratus).

Authors:  Chie Furuta; Sayoko Arakawa; Zhanquan Shi; Gen Watanabe; Kazuyoshi Taya
Journal:  Endocrine       Date:  2008-05-20       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.